0Suppliers
0Customers
3Debt Items
6Related Chains
Black Diamond Therapeutics, Inc. Suppliers
No suppliers on recordBlack Diamond Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.
Black Diamond Therapeutics, Inc. Customers
No clients on recordNo downstream customers found in our database for Black Diamond Therapeutics, Inc..
Black Diamond Therapeutics, Inc. Debt Obligations
| Instrument | Description | Confidence | Evidence |
|---|
| BDTX-DEBT-8128 |
Xbrl Convertible |
90%
|
xbrl convertible detail from xbrl 2020-12-31. |
| BDTX-DEBT |
Debt stack $18.8M |
90%
|
Market cache reports total debt of $18.8M. |
| BDTX-DEBT-8127 |
Warrants outstanding: 16000 |
90%
|
xbrl warrant detail from xbrl 2020-12-31. |
Black Diamond Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Black Diamond Therapeutics, Inc..
Black Diamond Therapeutics, Inc. Ownership
| Holder | Name | Confidence | Evidence |
|---|
| BDTX-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEME |
T. Rowe Price Investment Management, Inc. |
90%
|
13F overlay lists T. Rowe Price Investment Management, Inc. as top holder; 106 tracked holders. |
Black Diamond Therapeutics, Inc. Extended Supply Chain Network
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|
| CGEM |
Cullinan Therapeutics, Inc. |
100.00 |
2 |
|
| JNJ |
Johnson & Johnson |
100.00 |
2 |
|
| LEPU |
LEPU |
50.00 |
2 |
|
| AARVIK |
AARVIK |
50.00 |
2 |
|
| ALLIST |
ALLIST |
50.00 |
2 |
|
| AVBP |
ArriVent BioPharma, Inc. |
36.29 |
1 |
['spend'] |
